½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1441177

¼¼°èÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, Á¦Ç° ¹× ÃÖÁ¾ ¿ëµµº° ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® - »ê¾÷ ¿¹Ãø(2023-2030³â)

Global MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers) - Industry Forecast 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀå ±Ô¸ð´Â 2022³â 6¾ï 831¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³â 6¾ï 5,271¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 11¾ï 4,688¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È 7.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀåÀº ±¤¹üÀ§ÇÑ ÀÇ·á ±â¼ú Àü¸Á¿¡¼­ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇÏ°í ÀÖÀ¸¸ç, ½Å°æ ÁúȯÀÇ Á¤¹ÐÇÏ°í ÃÖ¼Ò Ä§½ÀÀûÀÎ Ä¡·á¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ÀÚ±â°ø¸í¿µ»ó(MRI)À» È°¿ëÇÏ¿© ³ú¿¡¼­ ¿Ü°úÀû ÀýÁ¦¼úÀ» À¯µµÇϵµ·Ï ¼³°èµÈ ´Ù¾çÇÑ Ã·´Ü ±â¼ú ¹× Àåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ½Ã¼úÀº ÁÖ·Î ³úÁ¾¾ç, °£Áú, ÆÄŲ½¼º´ µî Ç¥Àû Á¶Á÷ ÀýÁ¦°¡ ÇÊ¿äÇÑ ½Å°æ ÁúȯÀÇ Ä¡·á¸¦ ¸ñÀûÀ¸·Î ÇÕ´Ï´Ù. ºñÁî´Ï½º °üÁ¡¿¡¼­ º¼ ¶§, MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀåÀº ÀÇ·á±â±â ¹× ÇコÄÉ¾î ºÐ¾ßÀÇ ±â¾÷µé¿¡°Ô Å« ±âȸ°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ½Å°æ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í, ÃÖ¼Ò Ä§½ÀÀû Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½Ã¼úÀÇ À§Çè°ú ȸº¹ ½Ã°£À» ÁÙÀ̸鼭 ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö Àִ ÷´Ü ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ±× °á°ú, MRI À¯µµ ½Å°æ¿Ü°úÀû ÀýÁ¦ ½Ã½ºÅÛ Á¦Á¶¾÷ü¿Í °³¹ß¾÷üµéÀº Á¦Ç° ¹× ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ½Å°æ¿Ü°ú ¼ö¼úÀÇ Á¤È®¼º, Á¤¹Ðµµ, ¾ÈÀü¼ºÀ» Çâ»ó½ÃÅ°´Â ÷´Ü ±â¼úÀÇ ²÷ÀÓ¾ø´Â Çõ½Å°ú °³¹ßÀÔ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ´Â ±â¾÷µéÀº ÷´Ü ¿µ»ó ó¸® ±â´É, ·Îº¿ Áö¿ø ¹× ½Ç½Ã°£ ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá Â÷¼¼´ë MRI À¯µµÇÏ ÀýÁ¦ ½Ã½ºÅÛÀ» µµÀÔÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·á Àü¹®°¡µéÀÌ º¹ÀâÇÑ ½Ã¼úÀ» º¸´Ù ¾ÈÁ¤ÀûÀÌ°í È¿À²ÀûÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÙ »Ó¸¸ ¾Æ´Ï¶ó, ȯÀÚÀÇ °á°ú¿Í ¸¸Á·µµ¸¦ Çâ»ó½ÃÅ°´Â µ¥¿¡µµ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, MRI À¯µµÇÏ ÀýÁ¦¼úÀº ÁÖº¯ Á¤»ó ±¸Á¶¹°¿¡ ´ëÇÑ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 º´º¯ Á¶Á÷À» Á¤È®ÇÏ°Ô Á¶ÁØÇÒ ¼ö ÀÖ¾î ±âÁ¸ ¼ö¼ú ¹æ½Ä¿¡ ºñÇØ ¶Ñ·ÇÇÑ ÀÌÁ¡À» °¡Áö°í ÀÖ´Ù, º´º¯ Á¶Á÷À» Á¤È®ÇÏ°Ô Á¶ÁØÇÒ ¼ö ÀÖ¾î ±âÁ¸ ¼ö¼úÀû Á¢±Ù ¹æ½Ä¿¡ ºñÇØ ¶Ñ·ÇÇÑ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÀ¯·Î, ´ú ħ½ÀÀûÀÎ Ä¡·á¹ýÀ¸·ÎÀÇ ÀüȯÀÌ ÁøÇàµÇ¸é¼­ MRI À¯µµ ½Å°æ¿Ü°úÀû ÀýÁ¦¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å°ú Ä¡·á Æз¯´ÙÀÓÀÇ º¯È­ ¿Ü¿¡µµ ½ÃÀå ¼ºÀåÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, ½Å°æ Áúȯ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ƯÈ÷ ½ÅÈï±¹ÀÇ È¯ÀÚ ¼ö Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë, »óȯ ¹®Á¦, ±ÔÁ¦ Á¦¾à µî ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ´Â ¿©·¯ °¡Áö ¹®Á¦µéÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ ¾÷°è´Â ÀÌ·¯ÇÑ À庮À» È¿°úÀûÀ¸·Î ±Øº¹Çϱâ À§ÇÑ Àü·«Àû Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • Wheel of Fortune

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷/1Â÷ Á¤º¸¿ø
  • ½ÃÀå ±Ô¸ð ÃßÁ¤
  • ½ÃÀå ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

»óÀ§ ½ÃÀå ºÐ¼®

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °úÁ¦

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀå »ýÅ°è
  • IP ºÐ¼®
  • ¹«¿ª ºÐ¼®
  • ½ºÅ¸Æ®¾÷ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ÁÖ¿ä ÅõÀÚ ºÐ¼®
  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀï Á¤µµ

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °úÁ¦
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ Five Forces ºÐ¼®
  • ÇâÈÄ È¥¶õ¿¡ °üÇÑ Æ¯º°ÇÑ ÀλçÀÌÆ®

¼¼°èÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå °³¿ä
  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems and Accessories

¼¼°èÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • Ŭ¸®´Ð ¹× ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)

¼¼°èÀÇ MRI À¯µµ ½Å°æ¿Ü°ú ÀýÁ¦¼ú ½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ½ÃÀå °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï ±¸µµ

  • ÁÖ¿ä 5°³»ç ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2021³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÁÖ¿ä ¼º°ø Àü·«
  • ½ÃÀå¿¡¼­ÀÇ ÃÖ±Ù È°µ¿
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2021³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Medtronic
  • InSightec Ltd.
  • Elekta AB
  • Monteris Medical
  • Profound Medical
  • Boston Scientific Corporation
  • MR Solutions
  • MRI Interventions, Inc.
  • Varian Medical Systems
  • AngioDynamics
  • Abbott Laboratories
  • Hitachi Medical Systems
  • Siemens Healthineers
  • IMRIS, Deerfield Imaging
  • Accuray Incorporated
  • Perseon Corporation
  • Elekta AB
  • Isacord
  • Monteris Medical
  • Focal Therapeutics
  • Shamrad Electronics
LSH 24.03.21

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 608.31 million in 2022 and is poised to grow from USD 652.71 million in 2023 to USD 1146.88 million by 2031, growing at a CAGR of 7.3% in the forecast period (2024-2031).

The global MRI-guided neurosurgical ablation market represents a crucial segment within the broader medical technology landscape, offering innovative solutions for precise and minimally invasive treatment of neurological disorders. This market encompasses a range of advanced technologies and devices designed to utilize magnetic resonance imaging (MRI) for guiding surgical ablation procedures in the brain. These procedures are primarily aimed at treating conditions such as brain tumors, epilepsy, Parkinson's disease, and other neurological disorders that may require targeted tissue ablation. From a business perspective, the MRI-guided neurosurgical ablation market presents significant opportunities for companies operating in the medical device and healthcare sectors. With the increasing prevalence of neurological disorders globally and growing demand for minimally invasive treatment options, there is a rising need for advanced technologies that can improve patient outcomes while reducing procedural risks and recovery times. As a result, manufacturers and developers of MRI-guided neurosurgical ablation systems are witnessing a surge in demand for their products and services. One of the key drivers propelling market growth is the continuous innovation and development of cutting-edge technologies that enhance the precision, accuracy, and safety of neurosurgical procedures. Companies investing in research and development are introducing next-generation MRI-guided ablation systems equipped with advanced imaging capabilities, robotic assistance, and real-time monitoring features. These technological advancements not only empower healthcare professionals to perform complex procedures with greater confidence and efficiency but also contribute to better patient outcomes and satisfaction.

Moreover, the market is benefiting from the growing adoption of minimally invasive techniques in neurosurgery, driven by factors such as shorter hospital stays, reduced post-operative complications, and faster recovery times for patients. MRI-guided ablation offers distinct advantages over traditional surgical approaches by enabling precise targeting of diseased tissue while minimizing damage to surrounding healthy structures. This has led to a shift towards less invasive treatment modalities, thereby fueling the demand for MRI-guided neurosurgical ablation systems. In addition to technological innovation and shifting treatment paradigms, market growth is also influenced by factors such as increasing healthcare expenditure, rising awareness about neurological disorders, and expanding patient populations, particularly in emerging economies. However, challenges such as high initial costs, reimbursement issues, and regulatory constraints may pose obstacles to market expansion, necessitating strategic initiatives by industry players to address these barriers effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRI-Guided Neurosurgical Ablation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRI-Guided Neurosurgical Ablation Market Segmental Analysis

Global MRI-guided neurosurgical ablation market is segmented on the basis of technology, end use and region. By Technology, the market is segmented into MRI guided RF ablation systems, MRI guided laser ablation systems, MRI guided focused ultrasound systems and accessories. By end use, the market is segmented into Hospitals, Clinics and Ambulatory surgical centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global MRI-Guided Neurosurgical Ablation Market

The global MRI-guided neurosurgical ablation market has experienced significant growth in recent years, driven by several factors including technological advancements, increasing prevalence of neurological disorders, and rising demand for minimally invasive surgical procedures. One key market driver is the growing adoption of MRI-guided neurosurgical ablation techniques due to their ability to provide real-time imaging, precise targeting, and enhanced safety compared to traditional surgical methods. MRI-guided procedures allow surgeons to visualize the target tissue and surrounding structures with high resolution, enabling accurate placement of the ablation probe and minimizing damage to healthy brain tissue. This has led to improved patient outcomes, reduced complications, and shorter recovery times, driving the demand for MRI-guided neurosurgical ablation systems globally.

Restraints in the Global MRI-Guided Neurosurgical Ablation Market

However, despite the numerous advantages, the market also faces certain restraints that could hinder its growth trajectory. One notable restraint is the high cost associated with MRI-guided neurosurgical ablation procedures and equipment. The initial capital investment required for setting up MRI-guided surgical suites and purchasing specialized equipment can be substantial, limiting accessibility for healthcare facilities, particularly in emerging economies with constrained healthcare budgets. Moreover, reimbursement challenges and regulatory hurdles may further impede market expansion, particularly in regions where healthcare reimbursement policies are stringent or uncertain. Addressing these cost-related barriers and enhancing reimbursement frameworks will be crucial for broader adoption of MRI-guided neurosurgical ablation technologies worldwide.

Market Trends of the Global MRI-Guided Neurosurgical Ablation Market

In terms of trends, one prominent development in the MRI-guided neurosurgical ablation market is the ongoing innovation and development of advanced ablation techniques and platforms. Manufacturers are increasingly focusing on improving the precision, efficiency, and safety of neurosurgical ablation procedures through technological innovations such as real-time temperature monitoring, automated planning software, and integrated navigation systems. Additionally, there is a growing trend towards the integration of MRI-guided ablation systems with other imaging modalities, such as positron emission tomography (PET) or computed tomography (CT), to enhance the accuracy of targeting and treatment planning. These advancements are expected to drive further adoption of MRI-guided neurosurgical ablation techniques and expand their applications in treating various neurological conditions, including brain tumors, epilepsy, and movement disorders, thus fueling market growth in the coming years.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global MRI-Guided Neurosurgical Ablation Market by Product

  • Market Overview
  • MRI Guided RF Ablation Systems
  • MRI Guided Laser Ablation Systems
  • MRI Guided Focused Ultrasound Systems and Accessories

Global MRI-Guided Neurosurgical Ablation Market by End-use

  • Market Overview
  • Hospitals
  • Clinics and Ambulatory Surgical Centers

Global MRI-Guided Neurosurgical Ablation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • InSightec Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Profound Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR Solutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MRI Interventions, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IMRIS, Deerfield Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accuray Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perseon Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elekta AB
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Isacord
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monteris Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Focal Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shamrad Electronics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦